Immunocore Holdings (IMCR) Assets (2019 - 2026)
Immunocore Holdings (IMCR) posted Assets of $1.12 billion for Q2 2026, up 3.4% from $1.08 billion a year earlier and up 4.4% from the prior quarter.
Powered by 
Analysis
Immunocore Holdings (IMCR) Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Immunocore Holdings' Assets came in at $1.07 billion, up 5.7% from FY2024.
- Annual Assets has increased for six consecutive years, with a five-year compound annual growth rate of 32.6% (FY2020 to FY2025).
- In prior years, Immunocore Holdings' Assets was $1.01 billion in FY2024 (+69.1%), $597 million in FY2023 (+13.3%), $526.76 million in FY2022 (+26.9%) and $415.2 million in FY2021 (+59.5%).
- The Q2 2026 figure stands as the highest quarterly Assets in data going back to Q4 2019.
- On a year-over-year basis, Assets has increased in each of the last seven quarters, with growth averaging 13.3% over the last seven quarters.
- Over the past five years, the year-over-year growth in Assets ranged from 1.6% (Q3 2025) to 85.7% (Q2 2024).
- According to Business Quant data, Assets for the three prior quarters was $1.07 billion (Q1 2026), $1.07 billion (Q4 2025) and $1.1 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 148.07 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 147.68 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 132.77 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 96.05 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 51.41 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 205.00 Bn |
| 10 | Immunocore Holdings | 1.63 Bn | -1.86 Bn | 114.84 Mn | 1.12 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.12 Bn |
| Mar 31, 2026 | 1.07 Bn |
| Dec 31, 2025 | 1.07 Bn |
| Sep 30, 2025 | 1.10 Bn |
| Jun 30, 2025 | 1.08 Bn |
| Mar 31, 2025 | 1.03 Bn |
| Dec 31, 2024 | 1.01 Bn |
| Sep 30, 2024 | 1.08 Bn |
| Jun 30, 2024 | 1.02 Bn |
| Mar 31, 2024 | 993.99 Mn |
| Dec 31, 2023 | 597.00 Mn |
| Jun 30, 2023 | 555.50 Mn |
| Dec 31, 2022 | 525.07 Mn |
| Sep 30, 2022 | 496.67 Mn |
| Dec 31, 2021 | 407.34 Mn |
| Dec 31, 2020 | 268.79 Mn |
| Dec 31, 2019 | 243.44 Mn |
API Access
Immunocore Holdings Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=IMCR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "IMCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=IMCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();